Clinical Research Directory
Browse clinical research sites, groups, and studies.
Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension
Sponsor: Chinese Pulmonary Vascular Disease Research Group
Summary
Pulmonary hypertension represents a challenging and heterogeneous condition that is associated with high mortality and morbidity if left untreated. Artificial intelligence is used to study and develop theories and methods that simulate and extend human intelligence, which is being applied in fields related to cardiovascular diseases. The study intends to combine multimodal clinical data of patients who undergo right heart catheterization at Fuwai Hospital with artificial intelligence techniques to create programs that can screen and diagnose pulmonary hypertension.
Official title: Artificial Intelligence-Assisted Evaluation of Pulmonary Hypertension
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2022-06-01
Completion Date
2025-12-31
Last Updated
2025-04-08
Healthy Volunteers
Yes
Interventions
Right heart catheterization
RHC is commonly used essential test to make gold-standard diagnosis of PH with mPAP \>20 mmHg. All multimodal data from patients eligible for inclusion would be randomly assigned to development datasets (70% of the study population) to train the artificial intelligence models for the detection of PH, which would be validated and tested by other datasets (30% of the study population).
Locations (1)
Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China